HIF-EPO-Iron
(Unterschied zwischen Versionen)
(Die Seite wurde neu angelegt: „ '''HIF1''' {{tp|p=32464493|t=2020. Hypoxia inducible factor-1 protects against COVID-19: A hypothesis.|pdf=|usr=009}} '''Erythropoietin''' {{tp|p=32270515|t=…“) |
|||
| Zeile 7: | Zeile 7: | ||
{{tp|p=32479920|t=2020. Erythropoiesis-Stimulating Agent Treatment in Patients With COVID-19.|pdf=|usr=008}} | {{tp|p=32479920|t=2020. Erythropoiesis-Stimulating Agent Treatment in Patients With COVID-19.|pdf=|usr=008}} | ||
{{tp|p=32534130|t=2020. EPO in Patients With COVID-19: More Than an Erythropoietic Hormone.|pdf=|usr=008}} | {{tp|p=32534130|t=2020. EPO in Patients With COVID-19: More Than an Erythropoietic Hormone.|pdf=|usr=008}} | ||
| + | {{tp|p=32522574|t=2020. Coping with hypoxemia: Could erythropoietin (EPO) be an adjuvant treatment of COVID-19?|pdf=|usr=009}} | ||
| + | {{tp|p=32546125|t=2020. Erythropoietin as candidate for supportive treatment of severe COVID-19.|pdf=|usr=010}} | ||
'''Iron chelators''' | '''Iron chelators''' | ||
{{tp|p=32418885|t=2020. Commentary: Could iron chelators prove to be useful as an adjunct to COVID-19 Treatment Regimens?|pdf=|usr=009}} | {{tp|p=32418885|t=2020. Commentary: Could iron chelators prove to be useful as an adjunct to COVID-19 Treatment Regimens?|pdf=|usr=009}} | ||
Version vom 8. Juli 2020, 09:23 Uhr
HIF1
32464493 2020. Hypoxia inducible factor-1 protects against COVID-19: A hypothesis.
Erythropoietin
32270515 2020. Does recombinant human Erythropoietin administration in critically ill COVID-19 patients have miraculous therapeutic effects?
32479920 2020. Erythropoiesis-Stimulating Agent Treatment in Patients With COVID-19.
32534130 2020. EPO in Patients With COVID-19: More Than an Erythropoietic Hormone.
32522574 2020. Coping with hypoxemia: Could erythropoietin (EPO) be an adjuvant treatment of COVID-19?
32546125 2020. Erythropoietin as candidate for supportive treatment of severe COVID-19.
Iron chelators
32418885 2020. Commentary: Could iron chelators prove to be useful as an adjunct to COVID-19 Treatment Regimens?
